Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

Normal RCRI Score and Perioperative Management

RCRI Score Classification and Risk Factors

  • An RCRI score of 0-1 is considered normal/low risk, with a predicted major adverse cardiac event (MACE) rate of less than 1% after noncardiac surgery, according to the American College of Cardiology 1, 2
  • The Revised Cardiac Risk Index stratifies patients into distinct risk categories based on the number of risk factors present, with RCRI 0-1 having cardiac complication rates of 0.4-1.3%, representing normal/low-risk patients who can proceed directly to surgery without additional cardiac testing, as recommended by the American Heart Association 3, 1
  • Each of the six RCRI risk factors, including history of cerebrovascular disease and preoperative insulin treatment for diabetes mellitus, counts as one point toward the total score, as outlined by the American College of Cardiology 2, 1

Clinical Implications of Normal RCRI

  • Patients with RCRI 0-1 can proceed directly to surgery without additional preoperative cardiac testing, as the risk of major cardiac complications is less than 1%, according to the American Heart Association/American College of Cardiology 1, 2
  • No routine stress testing or advanced cardiac imaging is indicated for patients with RCRI 0-1, as stated by the American College of Cardiology 1
  • Standard perioperative monitoring is appropriate for patients with RCRI 0-1, as recommended by the American Heart Association/American College of Cardiology 2

Perioperative Management for Normal RCRI

  • The American Heart Association/American College of Cardiology recommends continuing chronic beta blockers if already prescribed (Class I) for patients with RCRI 0-1 1
  • The American Heart Association/American College of Cardiology recommends continuing statins if currently taking them (Class I) for patients with RCRI 0-1 1
  • The American Heart Association/American College of Cardiology suggests considering guideline-directed medical therapy for long-term cardiovascular risk reduction for patients with RCRI 0-1 1
  • Biomarker assessment (BNP/NT-proBNP) may be reasonable for additional risk stratification (Class 2a) for patients with RCRI 0-1, as stated by the American College of Cardiology 1